Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 15: 2569-2578, 2004
© 2004 American Society of Nephrology
doi: 10.1097/01.ASN.0000141464.02967.29

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freeburg, P. B.
Right arrow Articles by Abrahamson, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freeburg, P. B.
Right arrow Articles by Abrahamson, D. R.

BASIC SCIENCE

Divergent Expression Patterns for Hypoxia-Inducible Factor-1{beta} and Aryl Hydrocarbon Receptor Nuclear Transporter-2 in Developing Kidney

Paul B. Freeburg and Dale R. Abrahamson

Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas

Correspondence to Dr. Dale R. Abrahamson, Department of Anatomy and Cell Biology, University of Kansas Medical Center, MS 3038, 3901 Rainbow Boulevard, Kansas City, KS 66160. Phone: 913-588-7000; Fax: 913-588-2710; E-mail: dabrahamson{at}kumc.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The hypoxia-inducible factors (HIF) are {alpha}/{beta} heterodimeric transcription factors of the basic helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) superfamily and are chiefly responsible for cellular adaptation to oxygen deprivation. HIF function relies on the stabilization of the {alpha} subunit. When oxygen tension falls, HIF-{alpha} subunits translocate to the nucleus and, upon dimerization with HIF-{beta}, activate transcription of target genes, including vascular endothelial growth factor, vascular endothelial growth factor receptor-1 and -2, and WT-1, which are vital for kidney development. HIF-{beta} subunits are stable regardless of oxygen concentration and constitutively translocate to the nucleus. It was shown previously that HIF-1{beta} protein expression is nearly ubiquitous in newborn kidney and that HIF-1{beta} dimerizes with either HIF-1{alpha} or -2{alpha}. Here it is shown that aryl hydrocarbon receptor nuclear transporter-2 (ARNT2/HIF-2{beta}) also heterodimerized with HIF-1{alpha} and -2{alpha}. ARNT2/HIF-2{beta} protein was highly expressed in newborn kidney but decreased significantly with age, whereas HIF-1{beta} levels remained relatively constant. By immunohistochemical analysis, widespread expression of HIF-1{beta} was observed in developing and mature kidneys. ARNT2/HIF-2{beta} protein distribution was restricted to distal segments of developing nephrons and in mature kidney was confined specifically to thick ascending limb of Henle’s loop. The data presented here suggest that ARNT2/HIF-2{beta} is required at high levels during nephrogenesis in distal tubules and later exclusively in thick ascending limb. Furthermore, Hypoxyprobe-1 and lotus lectin co-localization studies showed that developing proximal convoluted tubules were the most severely hypoxic nephron segment in immature kidney. Because HIF-2{beta} protein was not abundantly expressed in this segment, it may not be engaged in mediating responses to severe hypoxia. The differential distribution patterns for HIF-1{beta} and -2{beta} suggest divergent roles during kidney development for these highly related bHLH-PAS proteins.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The basic helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) family of transcription factors functions as {alpha}/{beta} heterodimeric DNA binding complexes and regulates a remarkably diverse number of biologic events. These include responses to oxygen deprivation and exposure to toxins, control of circadian rhythms, and regulation of hormone signaling (1). The bHLH-PAS heterodimers typically consist of one broadly expressed, readily available member ({beta} subunit) that heterodimerizes with a partner ({alpha} subunit) that has a tightly restricted expression profile and is sensitive to environmental cues. Perhaps the most widely expressed and best understood protein in this family is the aryl hydrocarbon receptor nuclear transporter (ARNT), which acts as the {beta} subunit for transcriptional responses to both toxin exposure and hypoxic stimuli (2–6). To aid in metabolism of the toxin benzo[a]pyrene, ARNT heterodimerizes with the bHLH-PAS protein aryl hydrocarbon receptor (AHR) and binds to the xenobiotic response element located in the enhancer regions of the cytochrome P450 gene isoforms Cyp1a1, Cyp1a2, and Cyp1b1 (7). Expression of these proteins purges the system of the toxin by way of their metabolic activity toward benzo[a]pyrene. Ordinarily, AHR is held quiescent in the cytoplasm by binding heat shock protein 90 and AHR interaction factor. AHR is released by this complex, combines with ARNT, and induces gene expression upon binding of the toxin (8). AHR therefore acts as the {alpha} subunit of bHLH-PAS heterodimer because its function is reliant on an environmental insult, which in this case is the cellular toxin benzo[a]pyrene.

Another clearly defined role for ARNT as a {beta} subunit of bHLH-PAS heterodimers is in the hypoxia responsive pathway, where ARNT is now commonly known as hypoxia-inducible factor-1{beta} (HIF-1{beta}). Early studies of erythropoietin (Epo) gene expression led to the identification of a heterodimeric transcription factor that stimulates Epo expression in response to low oxygen tension (9). This factor was purified and found to contain ARNT (HIF-1{beta}) and a new member of the bHLH-PAS family, named HIF-1{alpha}. Since the discovery of the HIF-1{beta}/HIF-1{alpha} heterodimer (HIF-1), the biochemical behavior of these proteins in response to oxygen deprivation has been studied extensively. Most evidence indicates that HIF-1{beta} protein expression occurs in all cells and that the protein is stable and is found abundantly in the nucleus regardless of oxygen tension (10). HIF-1{alpha}, conversely, is regulated directly by cellular oxygen availability (11). When intracellular oxygen tension is sufficient to satisfy metabolic demands (normoxia), HIF-1{alpha} protein undergoes an oxygen-dependent hydroxylation on a highly conserved proline residue (12,13). This hydroxyproline residue is vital, because it renders HIF-1{alpha} recognizable by the von Hippel-Lindau ubiquitin ligase complex. Hydroxylated HIF-1{alpha} becomes polyubiquinated and rapidly destroyed by proteasomes. However, when oxygen tension falls below critical levels (hypoxia), HIF-1{alpha} escapes proline hydroxylation, is not recognized by von Hippel-Lindau, and therefore avoids proteasomal degradation. Stabilized HIF-1{alpha} then translocates to the nucleus, heterodimerizes with the readily available HIF-1{beta}, and binds the hypoxia-responsive element (HRE) located in the promoter/enhancer of HIF target genes. HIF-2{alpha}, initially called endothelial PAS domain protein, has very similar structural and biochemical properties to HIF-1{alpha} and also heterodimerizes with HIF-1{beta} (14–16). Among the genes induced by HIF-1 and -2 are those highly involved in kidney development, including vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1) and -2, angiopoietin-2, Tie-2, Epo, and WT-1 (17–23).

Although much has been learned about the {alpha} subunits of bHLH-PAS heterodimers (AHR and HIF-1{alpha} and -2{alpha}), relatively little is known about the HIF-{beta} counterparts. However, recent studies have suggested that {beta} bHLH-PAS proteins are more complex than initially thought. For example, five different splice variants of HIF-1{beta} have been identified in the rat (24), and additional isoforms have been shown to contain deletions at exon 5, 6, or 11 or an insertion at exon 20. Other HIF-1{beta} mRNA isoforms contain a variable number of codons in exon 16 encoding glutamine. Expression profiles and functions of each of the alternately spliced variants have yet to be described. In addition, in some cell lines, HIF-1{beta} protein is apparently sensitive to oxygen concentration and accumulates in hypoxia, as observed in a human neuroblastoma cell culture system (25).

HIF-1{alpha} and -2{alpha} both are required for proper development, as demonstrated in mice with targeted deletions of these genes (14,26,27). HIF-1{alpha} null embryos die at embryonic day 9.5 (E9.5) from cardiovascular and neural tube defects, as well as widespread mesenchymal cell death. HIF-2{alpha} knockout mice on the C57Bl/6 or 129/Sv genetic background die at E13.5 to E15.5 from bradycardia and lack of catecholamine synthesis. Overall vascular development in these mice, at least at the gross anatomic level, seems normal (14). HIF-2{alpha} mutants on the ICR/129Sv background, however, show severe vascular defects and die by E13.5 (15).

HIF-1{beta} null embryos die at E11 from abnormal hematopoietic and vascular development (28). A second {beta}-class bHLH-PAS protein, ARNT2 (HIF-2{beta}), has been identified and found to share 63% homology with HIF-1{beta} (29,30). HIF-2{beta} has subsequently been shown to form functional heterodimers with AHR, HIF-1{alpha}, and HIF-2{alpha} (30–32). In situ hybridization studies in developing mouse show that HIF-1{beta} is nearly ubiquitously expressed at E11 through postnatal day 1.5 (P1.5), whereas HIF-2{beta} mRNA is expressed most prominently in the brain and kidney at these stages (33). The in situ hybridizations in this earlier study demonstrated that HIF-2{beta} mRNA is expressed strongly in the outer cortex of developing kidney, although cellular identification is not possible because of the low-magnification fields presented. Unlike HIF-1{beta} mutants, HIF-2{beta} knockout mice survive until birth and, with the exception of stunted hypothalamus formation, seem to develop normally (34). Cultured neurons from HIF-2{beta}–/– mice show less induction of the hypoxia-inducible genes VEGF, Glut3, and Pgk compared with HIF-2{beta}+/+ neurons, and mobility shift DNA-binding assays of nuclear extracts from hypoxic cultures of wild-type neurons show both HIF-1{beta} and -2{beta} binding DNA as a complex with HIF-1{alpha} (34). These observations therefore suggest that HIF-2{beta} is capable of participating in hypoxic responses.

Crosses between HIF-1{beta}+/– and HIF-2{beta}+/– mutants revealed that progeny lacking any combination of at least two wild-type alleles of either {beta} subunit died by E8.5 (34). These experiments indicate that HIF-1{beta} and HIF-2{beta} have overlapping roles in early development and may compensate for loss of one another. After E8.5, however, HIF-{beta} subunit functions begin to diverge, and each protein has a unique, indispensable role in embryonic development, which has yet to be clearly defined. This is consistent with the restricted expression pattern seen for HIF-2{beta} during mouse development when compared with the ubiquitous expression pattern for HIF-1{beta} (33). We previously immunolocalized HIF-1{beta} protein expression in newborn mouse kidney and found that every cell type seemed to contain nuclear expression at that age (35). Although the developing kidney is one of two sites of intense HIF-2{beta} expression, this protein has not been studied in detail during metanephrogenesis. Here, we examined HIF-2{beta} protein expression beginning at the earliest stages of nephron development and continuing into maturity and compared expression patterns with those of HIF-1{beta}. Our findings show that HIF-2{beta} is selectively expressed in distal segments of developing nephrons and becomes restricted to thick ascending limb (TAL) of loop of Henle. We also show that, like HIF-1{beta}, HIF-2{beta} heterodimerizes with both HIF-1{alpha} and -2{alpha}, and that HIF-2{beta} protein expression in organ-cultured metanephroi is not regulated by oxygen levels.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Western Blots and Immunoprecipitations
Wild-type CD-1 mouse kidneys were dissected at 1 d, 7 d, and 6 wk of age and disrupted in a Dounce homogenizer in RIPA buffer supplemented with a protease inhibitor cocktail as described previously (35). After lysates were cleared by centrifugation at 4°C for 25 min at 15,000 x g, total protein concentrations were determined by the colorimetric Bio-Rad DC Protein Assay (Bio-Rad Laboratories, Hercules, CA). Equal amounts of protein (50 to 100 µg) were separated by 5 to 15% SDS-PAGE and transferred to nitrocellulose. Standard immunoblot techniques were then applied with the following antibodies: polyclonal HIF-1{beta} (Novus-Biologicals, Littleton, CO; 1:100) and polyclonal ARNT2 (HIF-2{beta}; sc-5581; Santa Cruz Biotechnology, Santa Cruz, CA; 1:50). The ECL reagent and ECL Hyperfilm (Amersham Pharmacia Biotech, Piscataway, NJ) were used to visualize the bands. For loading controls, membranes were also incubated with mouse monoclonal anti–smooth muscle actin antibody (1:100 dilution; Sigma-Aldrich, St. Louis, MO).

For immunoprecipitation experiments, lysates from 1-d-old kidneys were additionally cleared by incubation with protein A agarose (1 µl/10 µg total protein) for 15 min and then centrifuged again at 15,000 x g for 15 min. The clarified lysates then underwent immunoprecipitation with HIF-2{beta} antibodies, using procedures described previously (35). The immunoprecipitated proteins were analyzed on Western blots by standard protocols with monoclonal anti–HIF-1{alpha} and -2{alpha} antibodies used at a dilution of 1:100. Purified rabbit IgG (Sigma-Aldrich) was also used as a nonspecific control to demonstrate the specificity of the ARNT2 antibodies, and no bands were detected on Western blots probed with anti–HIF-1{alpha} or -2{alpha}.

Embryonic Kidney Organ Culture and Western Blots
Timed-pregnant CD-1 mice were killed and embryos were removed at E12. Metanephroi were dissected and cultured on PET membrane cell culture inserts (0.4-µm pore; BD Biosciences, San Jose, CA). Organ culture media and growth conditions were as described previously (35). Culture oxygen concentrations were set at either constant room air (~20% oxygen) or 5% oxygen for 5 d or at 20% oxygen for 4 d and then reduced to 2% for the final 24 h. After culture periods, kidneys were homogenized in RIPA buffer, protein concentrations were determined, and Western blots were performed as described above. In addition to HIF-1{beta} and -2{beta}, WT-1 (Santa Cruz Biotechnology; 1:50) and cyclo-oxygenase (Cox-2; Chemicon International, Temecula, CA; 1:200) antibodies were used to probe membranes. In some cases, explants were fixed and processed for immunohistochemistry as described below.

Peroxidase Immunohistochemistry
For immunohistochemical analysis, kidneys were dissected and frozen in OCT in isopentane in a dry-ice/acetone bath. Cryostat sections were cut at a thickness of 6 µm and air-dried. Sections were fixed for 10 min in ice-cold methanol, washed in PBS, and placed in 3% H2O2 in methanol for 10 min. Blocking of nonspecific protein interactions was achieved by incubating sections with 10% goat serum in PBS. Slides were then incubated in primary antibodies: Polyclonal anti–HIF-1{beta} and HIF-2{beta} diluted in PBS (1:100 and 1:50, respectively) for 1 h at room temperature in a humidified slide chamber. Sections were then washed with PBS, incubated sequentially with biotinylated secondary antibodies (15 µg/ml) and streptavidin-HRP conjugates for 30 min each, and color-developed with 3,3'-diaminobenzidine tetrahydrochloride. Rabbit IgG diluted in PBS at the same concentration as the primary antibodies served as a negative control.

Immunofluorescence Analysis
Sections (6 µm thick) of 3-d-old mouse kidney were fixed in 100% methanol on ice and incubated with polyclonal anti–HIF-2{beta} (1:50) and either fluorescein-conjugated Lotus lectin, to label proximal convoluted tubule (Sigma Chemical Co., St. Louis, MO; 1:200), or rhodamine-conjugated Dolichos Biflorus agglutinin (DBA), to label collecting duct (Vector Laboratories, Burlingame, CA; 1:10), for 30 min at room temperature. After three washes in PBS, Alexa Fluor 488–conjugated anti-rabbit antibody (Molecular Probes, Eugene, OR) was applied for 30 min at 1:200. Sections were again washed in PBS and permanently mounted with the fluorescence preserving reagent Prolong (Molecular Probes). Serial sections of 6-d-old mouse kidney were fixed in the same way for co-localization of HIF-2{beta} and Tamm-Horsfall protein (THP). HIF-2{beta} immunofluorescence was performed as described above on the first serial section, and goat anti-THP antibody (Cappel Laboratories, Durham, NC) was applied to the second serial section for 30 min at 1:200. Rabbit anti-goat fluorescein was added as a secondary antibody to the anti-THP–labeled slides, which were also mounted with Prolong. Irrelevant IgG was incubated with sections and treated sequentially with fluorescein and rhodamine-conjugated secondary antibodies for controls.

For identifying hypoxic tissues, pimonidazole hydrochloride (Hypoxyprobe-1; Chemicon) was injected intraperitoneally into 6-d-old mice (200 mg/kg), and fixation and labeling were carried out as before (35). In addition to the Hypoxyprobe-1 monoclonal antibody, sections were incubated with Lotus lectin-fluorescein (1:200) for 30 min at room temperature. Sections from saline-injected mice were also immunolabeled for Hypoxyprobe-1 and served as controls.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
HIF-{beta} Protein Expression
Total mouse kidney protein was analyzed for HIF-1{beta} and -2{beta} by quantitative Western blots. Three stages of development were examined: 1 d, 7 d, and 8 wk of age (Figure 1A). HIF-1{beta} protein was readily detectable on blots at each age, with a slight increase in expression at day 7. HIF-2{beta} was strongly expressed in newborn kidney and decreased significantly at 7 d of age. In 8-wk-old kidney, HIF-2{beta} protein was barely detectable by Western blot.



View larger version (65K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. (A) Total renal hypoxia-inducible factor-2{beta} (HIF-2{beta}) protein expression decreases with age. Quantitative Western blots for HIF-1{beta} and -2{beta} with kidney lysates from newborn (Nb), 7-d-old, and 8-wk-old mouse kidneys revealed sustained expression of HIF-1{beta} throughout kidney maturation, with a peak at 7 d of age. By contrast, HIF-2{beta} expression was most intense in newborn kidney, was significantly decreased by day 7, and was barely detectable at 8 wk. Anti–smooth muscle actin staining of blots serves as loading controls. (B) HIF-2{beta} heterodimerizes with both HIF-1{alpha} and -2{alpha}. Proteins immunoprecipitated by HIF-2{beta} IgG from 3-d-old mouse kidney were analyzed by Western blot with HIF-1{alpha}– and -2{alpha}–specific antibodies. Both {alpha} subunits were evident by Western blot, demonstrating that HIF-2{beta} forms a complex with both {alpha} subunits. NS, nonspecific bands detected in both cases by secondary antibody.

 
To determine whether HIF-2{beta} heterodimerizes with either HIF-1{alpha} or HIF-2{alpha}, we conducted immunoprecipitation and Western blot experiments of newborn kidney lysates. Both HIF-1{alpha} and -2{alpha} proteins were observed on Western blots of the HIF-{beta} immune complexes, revealing that HIF-1{beta} formed heterodimers with both HIF-1{alpha} and -2{alpha} in developing kidney (Figure 1B).

Effect of Hypoxia on HIF-{beta} Protein Expression in Kidney Organ Culture
E12 kidney explants were cultured for 4 d at 20% oxygen followed by a 24-h exposure to 2% oxygen (Figure 2, left) or for 5 d at 5% oxygen (Figure 2, right), followed by Western blots for HIF1-{beta} and -2{beta}. In cultures that were exposed to acute or chronic hypoxia, no large changes in either HIF-1{beta} or -2{beta} protein expression were evident. However, the HIF-inducible genes WT-1 and Cox-2 both were induced by hypoxia in organ culture, but WT-1 increased only modestly at 5% oxygen (Figure 2).



View larger version (57K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. HIF-{beta} and HIF target gene expression in embryonic day 12 (E12) organ cultures that were exposed to hypoxia. E12 mouse metanephroi were dissected and cultured for 4 d in 20% oxygen and then shifted to a hypoxic environment (2% oxygen) for 1 d (left) or were cultured for 5 d in 5% oxygen (right). In both cases, HIF-1{beta} and -2{beta} protein levels remained constant. WT-1 and cyclo-oxengenase-2 (Cox-2), two potential HIF target genes during kidney development, however, showed increased protein levels in response to hypoxia in both cases, although upregulation of WT-1 at 5% oxygen seemed more modest. All blots are representative of two independent experiments.

 
HIF-1{beta} and -2{beta} Immunolocalization
HIF-1{beta} protein was found to be widely distributed in nuclei of apparently all cells in both developing and maturing kidney at every stage examined. In E14 kidney, HIF-1{beta} was expressed ubiquitously by mesenchymal cells, ureteric bud epithelium, and all cells in developing nephrons (Figure 3A). During later stages of kidney development and into maturity, widespread HIF-1{beta} protein expression persisted; nuclei within all tubular segments, interstitial cells, and cells within glomeruli all strongly labeled with anti–HIF-1{beta} antibody (see A in Figures 4 through 7 GoGoGo). Sections that were labeled with nonspecific rabbit IgG in place of HIF-1{beta} antibodies were negative in all cases (Figure 3D).



View larger version (146K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Immunolocalization of HIF-1{beta} and -2{beta} in E14 kidney. (A) HIF-1{beta} protein expression at E14 was nearly ubiquitous and uniformly intense. Strong nuclear staining was apparent in ureteric bud (UB), developing nephrons (N), and mesenchymal cells. (B) HIF-2{beta} protein expression was much more restricted and variable at E14 compared with HIF-1{beta}. Faint nuclear labeling was found in ureteric bud, uninduced mesenchyme in extreme outer cortex, but was particularly prominent in developing nephrons. (C) Higher-power views show that HIF-2{beta} protein was expressed strongly and specifically in the distal segment of developing nephrons (*), including cells that may form the macula densa. Weaker expression was also evident in the visceral (VE) and parietal epithelium (PE), which are destined to form the podocytes (Po) and Bowman’s capsule (BC), respectively (arrows). (D) Nonspecific rabbit IgG incubated with sections in place of primary antibodies served as controls, and no labeling was observed.

 


View larger version (155K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Sections of E12 metanephroi maintained for 5 d at room air (~20% oxygen; A and C) or 5% oxygen (B and D) labeled for HIF-1{beta} (A and B) and HIF-2{beta} (C and D). Hypoxia did not induce changes in either HIF-1{beta} or -2{beta} abundance or distribution. Note that a nephron segment that contained intense signal for HIF-2{beta} (arrows) seemed similar to that observed in native, E14 kidney (Figure 3).

 


View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 5. Expression of HIF-1{beta} and -2{beta} protein in 3-d-old (P3) mouse kidney. (A) HIF-1{beta} protein distribution was widespread at 3 d of age, and most cells showed strong nuclear staining. (B) HIF-2{beta}, conversely, remained tightly restricted at day 3. Developing nephrons (N) again showed especially strong nuclear labeling. Portions of a specific developing tubule segment projecting toward the medulla (arrows) also displayed strong nuclear reaction product.

 


View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 6. HIF-1{beta} and -2{beta} protein distribution in 7-d-old (P7) mouse kidney. (A) HIF-1{beta} protein localization at day 7 again showed extensive nuclear staining throughout the kidney, including glomeruli (G). (B) At day 7, HIF-2{beta} distribution was restricted to a specific tubular segment. In addition, this was the first age point examined at which specific glomerular labeling was observed. The inset shows podocyte labeling for HIF-2{beta} (P).

 


View larger version (169K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 7. HIF-1{beta} and -2{beta} protein expression in 10-d-old mouse kidney. (A) Similar to all other age points, HIF-1{beta} protein distribution at day 10 was nearly ubiquitous. Glomeruli (G) again were consistently positive for expression. (B) HIF-2{beta} expression at day 10 showed relatively little protein in the outer cortex, and only a subset of tubular segments showed labeling. In contrast to day 7, glomeruli now showed little or no staining for HIF-2{beta}. (C) Certain medullary tubules of 10-d-old kidney showed intense labeling for HIF-2{beta}.

 
In contrast to HIF-1{beta}, the distribution of HIF-2{beta} protein was highly restricted among the time points examined. At E14, HIF-2{beta} was seen in nuclei of ureteric bud epithelium and less intensely in mesenchymal cells of the outer cortex (Figure 3B). In early nephrons, both the visceral and parietal epithelium were weakly positive, but developing distal segments showed particularly intense HIF-2{beta} labeling (Figure 3, B and C).

As an additional test for whether HIF-1{beta} and/or -2{beta} changes in abundance or expression pattern, organ cultures of E12 kidneys maintained for 5 d at 20 or 5% oxygen were examined. As shown in Figure 4, no differences were observed.

In 3-d-old kidney, developing nephrons of the extreme outer cortex showed the same overall expression pattern observed in E14 kidney with especially strong localization to distal segments (Figure 5B). In addition, tubules projecting through the subcortical region also showed strong nuclear labeling at this age. The expression profile in 5-d-old kidney was indistinguishable from that in 3-d-old kidney (data not shown). In 1-wk-old kidney, HIF-2{beta} protein distribution was restricted to certain tubular segments (Figure 6B), and podocyte nuclei of maturing stage glomeruli were also labeled (Figure 6B, inset). By 10 d of age, restricted tubular expression persisted in the cortex, but glomerular expression was now absent (Figure 7B). The medulla of 10-d-old kidney showed intense HIF-2{beta} expression (Figure 7C). Finally, in fully mature, 8-wk-old kidney, HIF-2{beta} expression was diminished overall and found only sparsely in the cortex (Figure 8B). Medullary expression of HIF-2{beta} was prominent (Figure 8B, inset upper right), but glomeruli showed little expression (Figure 8, inset lower right).



View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 8. Immunolocalization of HIF-1{beta} and -2{beta} in 8-wk-old mouse kidney. (A) HIF-1{beta} protein expression persisted in all tubular segments and glomeruli (G), as seen throughout development. (B) HIF-2{beta} protein expression in the cortex was limited, and few positive tubular cells could be found (arrows). Glomeruli (G of inset) were negative. The medulla was the site of the most intensive HIF-2{beta} labeling at this stage (inset top left).

 
Identification of Tubular Segment Expressing HIF-2{beta}
For identifying specifically which tubule segment expressed HIF-2{beta}, co-localization studies with the tubule-specific markers Lotus lectin (specific for proximal convoluted tubule), DBA (specific for collecting duct), and THP (specific for TAL of Henle’s loop) were undertaken on sections of 6-d-old mouse kidney. In serial sections that were merged digitally, co-localization with THP showed that HIF-2{beta} protein was expressed in developing TAL of loop of Henle (Figure 9, A through C). Expression was restricted to TAL as no co-localization of HIF-2{beta} was apparent in the same section that dually labeled with proximal tubular marker Lotus lectin (Figure 9, D through F) or collecting duct–specific DBA (Figure 9, G through I). For controls, slides were incubated with nonspecific IgG and both fluorescein- and rhodamine-conjugated secondary antibodies (Figure 9J).



View larger version (51K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 9. Identification of HIF-2{beta}–positive tubular segment: Double labeling with tubule-specific markers. (A through C) Tamm-Horsfall’s protein (THP) is expressed intensely in the thick ascending limb (TAL) of Henle’s loop. Serial cryostat sections from 6-d-old kidney were labeled for THP (A) and HIF-2{beta} (B), and the resulting images were overlaid (C). THP and HIF-2{beta} expression patterns overlap in the majority of cells, demonstrating that TAL is the primary site of HIF-2{beta} protein expression. (D through F) The Lotus lectin specifically binds carbohydrates found on proximal tubule epithelial membranes. Cryostat sections from 3-d-old mouse kidney double labeled for fluorescein-conjugated Lotus lectin (D) and HIF-2{beta} showed no overlapping fluorescence, demonstrating that HIF-2{beta} is not expressed by proximal tubules. (G through I) Dolichos Biflorus agglutinin (DBA) binds specifically to collecting duct epithelium. Double labeling of DBA (G) and HIF-2{beta} (H) on the same 3-d-old kidney section revealed no co-localization (I), demonstrating that collecting duct epithelial cells are not sites of HIF-2{beta} expression. (J) Controls with nonspecific IgG treated sequentially with fluorescein- and rhodamine-conjugated secondary antibodies were negative for each set of experiments.

 
Identification of Hypoxic Nephron Segments
To identify nephron segments that contained hypoxic cells, we doubly labeled sections with Hypoxoyprobe-1 and tubule-specific lectins. Nearly all proximal tubules (Lotus lectin positive) in 6-d-old kidney were positive for Hypoxyprobe-1 labeling as well (Figure 10). Because HIF-2{beta} expression was excluded from proximal tubules (Figure 9F), it is thereby also excluded from the most severely hypoxic cells in developing kidney. In contrast to proximal tubules, medullary tissues of 6-d-old kidney were not labeled with Hypoxyprobe-1 (or Lotus lectin; Figure 11) and therefore were not severely hypoxic at this time.



View larger version (27K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 10. Identification of hypoxic cells in vivo. Using the hypoxia marker Hypoxyprobe-1, we identified severely hypoxic cells in 6-d-old mouse kidney. By double labeling with the Hypoxyprobe-1 (A) and Lotus lectin, a proximal convoluted tubule marker (B), we saw that proximal tubules were the only extremely hypoxic cells in 6-d-old kidney (merged image C). Some proximal tubules were not positive for Hypoxyprobe-1 (arrow). Glomeruli did not show Hypoxyprobe-1–specific fluorescence. (D) Control, saline-injected mice that were treated with Hypoxyprobe-1 antibodies showed no fluorescence.

 


View larger version (8K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 11. Section of medulla from 6-d-old mouse kidney showing only low levels of nonspecific background labeling for Hypoxyprobe-1 (A) or Lotus lectin (B). Images are merged in C.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
During nephrogenesis, renal mesenchymal cells and ureteric bud epithelium differentiate into numerous, distinct cell types in a spatially precise sequence. Transcriptional regulation of this intricate process is poorly understood, but proteins that belong to the bHLH-PAS family of transcription factors are highly expressed during kidney development, implicating them as candidate regulators of nephron formation (33,35,36). One {beta} subunit of these transcriptional complexes, HIF-1{beta} (ARNT1), is expressed ubiquitously in newborn mouse kidney (35). A highly related {beta} subunit, HIF-2{beta} (ARNT2), is also expressed at very high levels in developing kidney and brain (33,36), but the expression patterns of HIF-2{beta} had not yet been studied extensively. Our aims here were to define clearly the expression patterns of HIF-2{beta} in kidney development and compare directly its distribution with HIF-1{beta}. We found that HIF-1{beta} protein was expressed ubiquitously at every age examined, whereas HIF-2{beta} expression was tightly restricted. We also sought to determine with which HIF-{alpha} proteins HIF-2{beta} heterodimerized and found both HIF-1{alpha} and -2{alpha} present in complexes immunoprecipitated with anti–HIF-2{beta} antibodies. Despite that HIF-2{beta} heterodimerized with both HIF-{alpha} subunits, HIF-2{beta} protein was not found in the most extremely hypoxic cells, which we determined to be proximal tubule epithelium. By contrast, HIF-2{beta} was expressed predominantly in distal segments of developing nephrons and became restricted to TAL of Henle’s loop. In addition, we found that neither HIF-{beta} subunit was prominently induced by hypoxia in metanephric organ cultures but that two potential HIF target genes that are important for kidney development, WT-1 and Cox-2, were upregulated in low oxygen tension.

Northern blot analysis and in situ hybridization experiments have demonstrated intense mRNA expression of HIF-1{beta} and -2{beta} in developing kidney (36). These experiments, however, did not examine expression beyond P1.5 or specifically address protein expression. By quantitative Western blot, we showed abundant HIF-1{beta} protein expression in kidneys at birth, 7 d, and 8 wk of age. Our data are consistent with the previous in situ hybridization experiments (36) in that our Western blots showed very intense expression of HIF-2{beta} in newborn kidney. We extended the analysis to include maturing kidneys and showed that HIF-2{beta} protein expression declined significantly at P7 and was barely detectable on Western blots at 8 wk of age. The relative abundance of HIF-2{beta} in developing kidney and decline in maturation therefore suggest a role for this protein in renal organogenesis.

HIF-1{beta} and -2{beta} are capable of binding a number of bHLH-PAS domain proteins, including HIF-1{alpha}, HIF-2{alpha}, and AHR (30–32). Of particular interest to kidney development are the heterodimers consisting of HIF-1{beta} and either HIF-{alpha} subunit, because many of the genes that are known to be induced by these complexes are crucial for kidney formation, including VEGF, VEGFR-1 and -2, WT-1, angiopoietin-2, Tie-2, and Epo. We showed previously, by immunoprecipitation and Western blotting, that HIF-1{beta} forms heterodimers with both HIF-1{alpha} and -2{alpha} in developing kidney (35). Here we show that HIF-2{beta}, in the same way, complexes with either {alpha} subunit in 3-d-old mouse kidney. Which genes are targeted by HIF-2{beta}–containing complexes has yet to be clearly defined. However, cultured neurons from HIF-2{beta}–/– mice show less induction of VEGF in response to hypoxia than HIF-2{beta}+/+ neurons, suggesting that VEGF may be a target gene for heterodimers that contain HIF-2{beta} (34).

By applying immunoperoxidase techniques, we compared HIF-1{beta} and -2{beta} expression patterns at various stages of kidney development. At E14, HIF-2{beta} protein was expressed specifically in the ureteric bud and at particularly high levels in distal segments of developing nephrons. Visceral and parietal epithelia, which eventually form the podocytes and Bowman’s capsule, respectively, also showed positive staining, although at weaker levels. Mesenchymal cells of the outer cortex of E14 kidneys were also weakly positive. At 3 d of age, the expression pattern in the early nephric figures of the extreme outer cortex persisted. In addition, a specific elongating tubular segment showed prominent nuclear labeling. This segment proved to be developing TAL of Henle’s loop, by co-distribution immunofluorescence analysis with THP on serial sections (37). There was a dramatic change in the expression pattern observed at day 7, where, in addition to TAL, glomerular podocytes were now positive for HIF-2. In mature, 8-wk-old kidneys, expression was once again restricted to TAL, with no apparent glomerular labeling. In contrast to HIF-2{beta}, strong nuclear HIF-1{beta} labeling was observed at every stage examined and in nearly every cell. These immunohistochemical expression patterns are consistent with the quantitative Western blots. HIF-1{beta} expression was widespread and abundant at all ages examined, whereas HIF-2{beta} was highly expressed in developing kidney in many cell types but with age became restricted to TAL, and, quantitatively, lower levels were detected on immunoblots.

We have used the hypoxia marker Hypoxyprobe-1 and immunofluorescence microscopy to identify extremely hypoxic cells within newborn mouse kidney (35). Here, we show in 6-d-old kidney that the vast majority of hypoxic cells are Lotus lectin positive and therefore correspond to proximal tubular epithelium. Surprising, even though HIF-2{beta} co-immunoprecipitated the hypoxia responsive proteins HIF-1{alpha} and -2{alpha}, HIF-2{beta} did not immunolocalize to proximal tubules. This suggests that HIF-2{beta} may not participate in the hypoxic response pathway in the most intensely hypoxic cells. However, Hypoxyprobe-1 is optimally reactive only in extremely hypoxic cells (<1% O2) (38). We therefore cannot rule out that mild hypoxia (2 to 18% O2) may occur in glomeruli or TAL and that HIF-2{beta} could mediate hypoxia-induced gene expression in these cells.

Whether HIF-1{beta} gene expression is increased in hypoxia or not is unclear. In most systems analyzed, HIF-1{beta} protein levels remain constant regardless of oxygen tension, whereas in certain cell types, such as human neuroblastoma cells, HIF-1{beta} protein accumulates under hypoxic stress (25,39). We show here in E12 metanephric organ cultures that oxygen tension had no effect on either HIF-1{beta} or -2{beta} protein levels or their expression patterns. This evidence suggests that gene transactivation by HIF in developing kidney may be totally reliant on {alpha} subunit stabilization.

As described above, the VEGF gene is a potential target for HIF-2{beta}–containing heterodimers. What other genes relevant to kidney development might be induced by HIF-2{beta} transcription factors? A recent study identified a HRE in the WT-1 gene promoter and shown that HIF-1 activates transcription of this gene in hypoxia (23). This study showed by DNA-binding electrophoretic mobility shift assays that the transcription factor that induced the HRE in the WT-1 promoter contained HIF-1{alpha}, but the {beta} subunit was not identified. In early kidney development, WT-1 is expressed in renal mesenchyme and developing nephrons and then becomes localized specifically to podocytes (40). Our studies presented here show that HIF-2{beta} was expressed in renal mesenchymal cells and early nephrons as well as in podocytes at day 7. We therefore suggest that the HIF complex driving WT-1 expression may include either HIF-1{beta} or -2{beta}. Cox-2 displays an expression pattern remarkably similar to that of HIF-2{beta} in mouse kidney. Cox-2 is expressed exclusively in macula densa cells and TAL (41). Our studies also demonstrated that Cox-2 expression was induced in hypoxic kidney organ cultures, suggesting that Cox-2 might be an additional target of HIF-2{beta}, but this speculation demands further inquiry.

Studies of neuronal cell lines overexpressing HIF-2{beta} with SIM-1, which is highly expressed in developing kidney, may give more insight into which genes HIF-2{beta} specifically targets (42,43). These earlier reports showed that Neuro-2a cells overexpressing HIF-2{beta} showed strong induction of laminin {alpha}2, which is a component of the laminin-2 trimer ({alpha}2{beta}1{gamma}1). This laminin isoform is expressed at low levels by Henle’s loop, distal tubule, Bowman’s capsule, and collecting duct epithelium (44). We observed HIF-2{beta} expression in primitive nephrons in cells that eventually form distal tubule, Bowman’s capsule (parietal epithelium), and collecting duct (ureteric bud) as well as Henle’s loop. Perhaps HIF containing HIF-2{beta} is driving laminin {alpha}2 expression in these cells. Another potential HIF-2{beta} target identified in Neuro-2a cells is the janus kinase 2, which is partially responsible for expression of cytokine-stimulated inducible nitric oxide synthase in kidney epithelial cells (45). Again, these putative HIF-2{beta} targets in developing kidney need further experimental confirmation.

We have hypothesized previously that a delicate balance of HIF protein expression and stabilization occurs in various cell types during nephrogenesis so that different HIF heterodimers predominate in certain cell types and lead to selective transcription of different HIF target genes (46). The current study supports this hypothesis by showing differential expression patterns for HIF-1{beta} and -2{beta} during kidney development: HIF-1{beta} distribution was widespread, but HIF-2{beta} was most abundant initially in distal nephric segments and then became restricted to TAL. The cellular availability of {alpha} subunits and competition for binding HIF-{beta} may determine which HIF target genes will be expressed and therefore has a vital role in determining cellular phenotype. The events (e.g., microenvironmental oxygen tension) that prompt formation of a particular HIF heterodimer and the precise temporal and spatial occurrence of these events need to be investigated thoroughly in developing kidney to gain a better understanding of the HIF-mediated transcriptional regulation.


    Acknowledgments
 
This study was funded by National Institutes of Health Grants DK052483 and DK065123.

We thank Kathryn Isom, Eileen Roach, and Pat St. John for technical help.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Crews ST: Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev 12: 607–620, 1998[Free Full Text]
  2. Hoffman EC, Reyes H, Chu F, Sander F, Conley LH, Brooks BA, Hankinson O: Cloning of a subunit of the DNA binding form of the Ah (dioxin) receptor. Science 252: 954–958, 1991[Abstract/Free Full Text]
  3. Rowlands JC, Gustafsson JA: Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 27: 109–134, 1997[Medline]
  4. Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92: 5510–5514, 1995[Abstract/Free Full Text]
  5. Jiang BH, Rue EA, Wang GL, Semenza GL: Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271: 17771–17778, 1996[Abstract/Free Full Text]
  6. Wang GL, Semenza GL: Purification and characterization of HIF-1. J Biol Chem 270: 1230–1237, 1995[Abstract/Free Full Text]
  7. Denison MS, Whitlock JP Jr: Xenobiotic-inducible transcription of cytochrome P450 genes. J Biol Chem 270: 18175–18178, 1995[Free Full Text]
  8. Ma Q, Whitlock JP Jr: A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin. J Biol Chem 272: 8878–8884, 1997[Abstract/Free Full Text]
  9. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE: Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci U S A 88: 5680–5684, 1991[Abstract/Free Full Text]
  10. Semenza GL: HIF-1, O2, and the 3 PHDs: How animal cells signal hypoxia to the nucleus. Cell 107: 1–3, 2001[CrossRef][Medline]
  11. Jiang GH, Semenza GL, Bauer C, Marti HH: HIF-1 levels vary exponentially over a physiologically relevant range of oxygen tension. Am J Physiol 271: C1172–C1180, 1996
  12. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG: HIF{alpha} targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292: 464–468, 2001[Abstract/Free Full Text]
  13. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielber J, Gaskell SJ, von Kriegsheim A, Hebetreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ: Targeting of HIF-1{alpha} to the von Hipppel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468–472, 2001[Abstract/Free Full Text]
  14. Tian H, Hammer RE, Matsumoto AM, Russell DW, McKnight SL: The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12: 3320–3324, 1998[Abstract/Free Full Text]
  15. Peng J, Zhang L, Drysdale L Fong GH: The transcription factor EPAS1/hypoxia-inducible factor 2{alpha} plays an important role in vascular remodeling. Proc Natl Acad Sci U S A 97: 8386–8391, 2000[Abstract/Free Full Text]
  16. O’Rourke JF, Tian YM, Ratcliffe PJ, Pugh CW: Oxygen-regulated and transactivating domains of endothelial PAS protein 1: Comparison with HIF-1{alpha}. J Biol Chem 274: 2060–2071, 1999[Abstract/Free Full Text]
  17. Levy AP, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270: 13333–13340, 1995[Abstract/Free Full Text]
  18. Liu Y, Cox SR, Morita T, Kourenbanas S: Hypoxia regulates VEGF expression in endothelial cells: Identification of a 5' enhancer. Circ Res 77: 638–643, 1995[Abstract/Free Full Text]
  19. Kappel A, Ronicke V, Damert A, Flamme I, Risau W, Breir G: Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood 93: 4284–4292, 1999[Abstract/Free Full Text]
  20. Gerber HP, Condorelli F, Park J, Ferrara N: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes: Flt-1, but not Flk-1/KDR, is upregulated in hypoxia. J Biol Chem 272: 23659–23667, 1997[Abstract/Free Full Text]
  21. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Weigand SJ, Radziejeuski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55–60, 1997[Abstract/Free Full Text]
  22. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Hinda Y: Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274: 15732–15739, 1999[Abstract/Free Full Text]
  23. Wagner KD, Wagner N, Wellmann S, Scheley G, Bondke A, Theres H, Scholz H: Oxygen-regulated expression of the Wilms’ tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J 17: 1364–1366, 2003[Abstract/Free Full Text]
  24. Korkalainen M, Tuomisto J, Pohjanvirta R: Identification of novel splice variants of ARNT and ARNT2 in the rat. Biochem Biophys Res Commun 303: 1095–1100, 2003[CrossRef][Medline]
  25. Stolze I, Berchner-Pfannschmidt U, Freitag P, Wotzlaw C, Rossler J, Frede S, Acker H, Fandrey J: Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells. Blood 100: 2623–2628, 2002[Abstract/Free Full Text]
  26. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassman M, Gearhart JD, Lawler AM, Yu AY, Semenza GL: Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1{alpha}. Genes Dev 12: 149–162, 1998[Abstract/Free Full Text]
  27. Ryan HE, Lo J, Johnson RS: HIF-1{alpha} is required for solid tumor formation and embryonic vascularization. EMBO J 17: 3003–3015, 1998
  28. Maltepe E, Schmidt JV, Baunoch D, Bradford CA, Simon MC: Abnormal angiogenesis and responses to glucose deprivation in mice lacking the protein ARNT. Nature 386: 403–407, 1997[CrossRef][Medline]
  29. Drutel G, Kathmann M, Heron A, Schwartz JC, Arrang JM: Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator (ARNT). Biochem Biophys Res Commun 225: 333–339, 1996[CrossRef][Medline]
  30. Hirose K, Morita M, Ema M, Mimura J, Hamada H, Fujii H, Saijo Y, Gotoh O, Sogawa K, Fujii-Kuriyama Y: cDNA cloning and tissue specific expression of a novel basic-helix-loop-helix/PAS factor (ARNT2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (ARNT). Mol Cell Biol 16: 1706–1713, 1996[Abstract]
  31. Maltepe E, Keith B, Arsham A, Brorson J, Simon M: The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia. Biochem Biophys Res Commun 273: 231–238, 2000[CrossRef][Medline]
  32. Powell WH, Hahn ME: Identification and functional characterization of hypoxia-inducible factor 2{alpha} from the estuarine teleost, Fundulus heteroclitus: Interaction of HIF-2{alpha} with two ARNT2 splice variants. J Exp Zool 294: 17–29, 2002[CrossRef][Medline]
  33. Aitola MH, Pelto-Huikko MT: Expression of Arnt and Arnt2 mRNA in developing murine tissues. J Histochem Cytochem 51: 41–54, 2003[Abstract/Free Full Text]
  34. Keith B, Adelman DM, Simon MC: Targeted mutation of the murine arylhydrocarbon receptor nuclear translocator 2 (ARNT2) gene reveals partial redundancy with ARNT. Proc Natl Acad Sci U S A 98: 6692–6697, 2001[Abstract/Free Full Text]
  35. Freeburg PB, Robert B, St. John PL, Abrahamson DR: Podocyte expression of hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development. J Am Soc Nephrol 14: 927–938, 2003[Abstract/Free Full Text]
  36. Jain S, Maltepe E, Lu MM, Simon C, Bradfield CA: Expression of ARNT, ARNT2, HIF1{alpha}, HIF-2{alpha}, and Ah receptor mRNAs in the developing mouse. Mech Dev 73: 117–123, 1998[CrossRef][Medline]
  37. Hoyer JR, Resnick JS, Michael AD, Vernier RL: Ontogeny of Tamm-Horsfall urinary glycoprotein. Lab Invest 30: 757–761, 1974[Medline]
  38. Arteel GE, Thurman RG, Yates JM, Raleigh JA: Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72: 889–895, 1995[Medline]
  39. Catron T, Mendiola MA, Smith SM, Born J, Walker MK: Hypoxia regulates avian cardiac Arnt and HIF-1{alpha} mRNA expression. Biochem Biophys Res Commun 225: 602–607, 2001
  40. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB: The expression of the Wilms’ tumour gene, WT1, in the developing mammalian embryo. Mech Dev 40: 85–97, 1993[CrossRef][Medline]
  41. Kramer BK, Kammerl MC, Komhoff M: Renal cyclooxygenase-2 (Cox-2). Physiological, pathophysiological, and clinical implications. Kidney Blood Press Res 27: 43–62, 2004[CrossRef][Medline]
  42. Liu C, Goshu E, Wells A, Ran CM: Identification of downstream targets of SIM1 and ARNT2, a pair of transcription factors essential for neuroendocrine cell differentiation. J Biol Chem 278: 44857–44867, 2003[Abstract/Free Full Text]
  43. Fan CM, Kuwana E, Bulfone A, Fletcher CF, Copeland NG, Jenkins NA, Crews S, Martinez S, Puelles L, Rubenstein JL, Tessier-Lavigne M: Expression of the two murine homologs of Drosophila single-minded suggests possible roles in embryonic patterning and in the pathogenesis of Down syndrome. Mol Cell Neurosci 7: 1–16, 1996[CrossRef][Medline]
  44. Miner JH: Renal basement membrane components. Kidney Int 56: 2016–2024, 1999[CrossRef][Medline]
  45. Poljakovic M, Nygren JM, Persson K: Signalling pathways regulating inducible nitric oxide synthase expression in human kidney epithelial cells. Eur J Pharmacol 469: 21–28, 2003[CrossRef][Medline]
  46. Freeburg PB, Abrahamson DR: Hypoxia-inducible factors and kidney vascular development. J Am Soc Nephrol 14: 2723–2730, 2003[Abstract/Free Full Text]
Received for publication April 14, 2004. Accepted for publication July 15, 2004.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. L. Chevalier and M. S. Forbes
Generation and Evolution of Atubular Glomeruli in the Progression of Renal Disorders
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 197 - 206.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
K. Shchors, E. Shchors, F. Rostker, E. R. Lawlor, L. Brown-Swigart, and G. I. Evan
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta
Genes & Dev., September 15, 2006; 20(18): 2527 - 2538.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. B. Rankin, J. E. Tomaszewski, and V. H. Haase
Renal cyst development in mice with conditional inactivation of the von hippel-lindau tumor suppressor.
Cancer Res., March 1, 2006; 66(5): 2576 - 2583.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal